Author

A. Burgener

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

K. Birse· 2 shared A. Borgognone· 1 shared A. C. Collier· 1 shared A. R. Berard· 1 shared B. Clotet· 1 shared B. Mothe· 1 shared B. Oriol· 1 shared B. Richardson· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. Birse

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivOct 3, 2021

Gut Microbiome Signatures Linked to HIV-1 Reservoir Size and Viremia Control

A. Borgognone, M. Noguera-Julian, B. Oriol…·R. Paredes

The paper identifies gut microbiome signatures, specifically the Bacteroidales/Clostridiales ratio, associated with HIV-1 reservoir size and viremia control in a clinical trial.

DOI 10.1186/s40168-022-01247-6

humanmetagenomics

𝕏 PostBluesky

ImmunologybioRxivAug 3, 2020

Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection

S. M. Hughes, C. N. Levy, F. Calienes…·F. Hladik

This study shows that oral TDF/FTC antiretroviral drugs induce a type I/III interferon signature in the gut without HIV infection, potentially affecting immune responses.

DOI 10.1016/j.xcrm.2020.100096

humanbulk RNA-seq

𝕏 PostBluesky